Linked Life Data

17199181

Source:http://linkedlifedata.com/resource/pubmed/id/17199181

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-1-2
pubmed:abstractText
Recombinant tissue Plasminogen Activator (rtPA) is one of the more and more often used therapies in ischemic stroke. Main adverse effect of rtPA could be bleeding in different anatomical sites. Onset of the stroke is often associated with falls due to sudden limb weakness. Mild trauma can be not reported by patients and their families and can leave no visible signs on the skin. Thrombolytic therapy given in such cases can cause potentially dangerous complication such as subcutaneous or subfascial hematoma. The article presents two cases of patients with ischemic stroke who received thrombolytic therapy with subsequent complication of wide-spread subcutaneous hematomas.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0028-3843
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
536-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:articleTitle
Widespread subcutaneous haematoma after thrombolytic therapy in stroke patients. Mild falls at stroke onset may be dangerous.
pubmed:affiliation
2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
pubmed:publicationType
Journal Article, Case Reports